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Dietary Cholesterol, Rather than Liver Steatosis, Leads
to Hepatic Inflammation in Hyperlipidemic Mouse
Models of Nonalcoholic Steatohepatitis
Kristiaan Wouters,1 Patrick J. van Gorp,1 Veerle Bieghs,1 Marion J. Gijbels,1 Hans Duimel,1 Dieter Lütjohann,2 Anja Kerksiek,2
Roger van Kruchten,1 Nobuyo Maeda,3 Bart Staels,4 Marc van Bilsen,1 Ronit Shiri-Sverdlov,1* and Marten H. Hofker5*
Nonalcoholic steatohepatitis (NASH) involves liver lipid accumulation (steatosis) combined with
hepatic inflammation. The transition towards hepatic inflammation represents a key step in patho-
genesis, because it will set the stage for further liver damage, culminating in hepatic fibrosis, cirrhosis,
and liver cancer. The actual risk factors that drive hepatic inflammation during the progression to
NASH remain largely unknown. The role of steatosis and dietary cholesterol in the etiology of diet-
induced NASH was investigated using hyperlipidemic mouse models fed a Western diet. Livers of
male and female hyperlipidemic (low-density lipoprotein receptor–deficient [ldlr/] and apoli-
poprotein E2 knock-in [APOE2ki]) mouse models were compared with livers of normolipidemic
wild-type (WT) C57BL/6J mice after short-term feeding with a high-fat diet with cholesterol (HFC)
and without cholesterol. Whereas WT mice displayed only steatosis after a short-term HFC diet,
female ldlr/ and APOE2ki mice showed steatosis with severe inflammation characterized by infil-
trationofmacrophagesand increasednuclear factorB(NF-B)signaling.Remarkably,male ldlr/
and APOE2ki mice developed severe hepatic inflammation in the absence of steatosis after 7 days on
an HFC diet compared with WT animals. An HFC diet induced bloated, “foamy” Kupffer cells in
male and female ldlr/ and APOE2ki mice. Hepatic inflammation was found to be linked to in-
creased plasma very low-density lipoprotein (VLDL) cholesterol levels. Omitting cholesterol from the
HFC diet lowered plasma VLDL cholesterol and prevented the development of inflammation and
hepatic foamcells.Conclusion:Thesefindings indicate thatdietary cholesterol,possibly in the formof
modified plasma lipoproteins, is an important risk factor for the progression to hepatic inflammation
in diet-induced NASH. (HEPATOLOGY 2008;48:474-486.)
Nonalcoholic fatty liver disease (NAFLD) is acondition ranging from benign lipid accumula-tion in the liver (steatosis) to steatosis combined
with inflammation. The latter is referred to as nonalco-
holic steatohepatitis (NASH). NAFLD may be consid-
ered the hepatic event in the metabolic syndrome and is
therefore linked with common metabolic syndrome risk
factors such as obesity, insulin resistance, hypertension,
and dyslipidemia.1 The prevalence of NAFLD in the gen-
eral population is increasing, but only a small proportion
Abbreviations: APOE2ki, apolipoprotein E2 knock-in; HE, hematoxilin-eosin; HFC, high-fat cholesterol; HFnC, high fat no cholesterol; KC, Kupffer cell; LDL,
low-density lipoprotein; ldlr/, low-density lipoprotein receptor–deficient; MCD, methionine choline–deficient; Mcp1, monocyte chemoattractant protein 1; NAFLD,
nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; NF-B, nuclear factor B; PCR, polymerase chain reaction; TC, total cholesterol; TG, triglyceride;
TNF, tumor necrosis factor; WT, wild-type.
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will develop NASH. Estimates in the United States are
that only 2%-3% of all adults have NASH, compared
with an estimation of 20% of Americans with NALFD.2
Steatosis alone is considered a relatively benign and
reversible condition. The transition toward NASH repre-
sents a key step in pathogenesis, because it will set the
stage for further damage to the liver including fibrosis,
cirrhosis, and liver cancer. The actual risk factors that
drive hepatic inflammation during the progression to
NASH remain largely unknown. Therefore, knowledge
about events that induce hepatic inflammation is of great
importance for the diagnosis and treatment of NASH.
Currently, NASH is thought to develop via the “two-hit”
model.3 According to this hypothesis, hepatic steatosis is the
critical first hit and prerequisite for further liver injury. A
second hit can be represented by oxidative stress.4 However,
recent reports have raised doubts about steatosis as a prereq-
uisite for development of inflammation during NASH pro-
gression.5-7 In line with these observations, we have shown
previously that in apolipoprotein E2 knock-in (APOE2ki)
mice, a mouse model with a human-like lipoprotein profile,
hepatic steatosis and inflammation (that is, steatohepatitis)
develop very rapidly when fed a Western diet with moderate
amounts of fat. After just 2 days of a Western diet enriched
with triglycerides and cholesterol, female APOE2ki mice
show marked liver inflammation8 that developed alongside
rather than subsequent to steatosis.
The APOE2ki mouse carries the defective human
APOE2 isoform that replaces the endogenous mouse apoe
gene. Apolipoprotein E is highly expressed in macrophages
and has been shown to influence several inflammatory pro-
cesses.9 Therefore, to exclude defects in apolipoprotein E as
the cause of such early inflammation in the liver, we first
investigated diet-induced NASH development in another
hyperlipidemic mouse model that does not have a defect in
apolipoprotein E: the low-density lipoprotein receptor–defi-
cient (ldlr/) mouse.10 C57BL6/J wild-type (WT) mice,
with the genetic background of both mouse models, were
used as a control. Second, pilot experiments revealed a dif-
ference between female and male ldlr/ and APOE2ki
mice, because the male mice did not develop steatosis after
short-term high-fat feeding. Consequently, we investigated
male hyperlipidemic APOE2ki and ldlr/ mice to deter-
mine whether steatosis is necessary for hepatic inflammation
to develop. Third, based on the results of these diet interven-
tion studies, a correlation was found between plasma total
cholesterol (TC) and hepatic inflammation. Therefore, the
role of plasma TC was further investigated.
Materials and Methods
Extended Materials and Methods can be found online,
Shortly:
In the first experiment, female C57BL6/J and ldlr/
mice were fed chow or high-fat diet with cholesterol
(HFC) (21% milk butter, 0.2% cholesterol) for 2, 4, 7,
and 21 days. In the second experiment, male C57BL6/J,
ldlr/, and APOE2ki mice were fed either an HFC diet
for 7 days or were kept on chow. In the third experiment,
male and female C57BL6/J, ldlr/, and APOE2ki mice
were fed an HFC diet or a high-fat diet without choles-
terol (HFnC) for 7 days. Collection of specimens, lipid
analysis, RNA isolation, complementary DNA synthesis,
and quantitative polymerase chain reaction (PCR) were
performed as described.8
Taqman Low Density Arrays. Taqman Low Density
Arrays 96a, containing 4  96 annotated and validated
individual TaqMan Gene Expression Assays (Supplemen-
tary Table 1), were performed. Per individual assay, 2 ng
complementary DNA of a single liver was loaded together
with TaqMan Universal PCR Master Mix. Each group
consisted of five mice. Data were normalized to Ppia ex-
pression.
Liver Histology. Four-micrometer paraffin-embed-
ded liver sections were stained with hematoxylin-eosin
(HE) and periodic acid-Schiff–diastase. Frozen liver sec-
tions (7 m) were fixed in acetone and stained with
CD68 (FA11) or Mac1 (M1/70). Pictures were taken
with a Nikon DMX1200 digital camera and ACT-1 ver-
sion 2.63 software.
Electron Microscopy. Livers were freshly isolated,
perfused, and fixed with 2.5% glutaraldehyde. Tissue
fragments were postfixed in 1% osmium tetroxide, dehy-
drated, and embedded in epoxy resin. Sections were cut
for light microscopy (toluidine blue) and electron micros-
copy. Electron microscopy sections were analyzed on a
Philips CM100 TEM.
Statistical Analysis. Data were analyzed using
Graphpad Prism 4.0. Groups were compared using two-
tailed nonpaired t tests or analysis of variance with a Dun-
net posttest based on the statistical relevance. Data are
expressed as the mean  standard error of the mean and
were considered significant at P  0.05.
Results
Plasma Lipid Levels in Female Hyperlipidemic
Mouse Models. Female ldlr/, APOE2ki, and WT
mice were fed HFC diet for up to 3 weeks, and changes in
plasma lipids were monitored (experiment 1). Results on
female APOE2ki mice have been published previously8
and are included in Fig. 1 (black bars) for clarity. WT
mice displayed only minor changes in their lipid profile.
Compared with control chow levels, female ldlr/ mice
showed increased plasma triglyceride (TG) (Fig. 1A) and
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free fatty acid (Fig. 1B) levels and diet-induced hypercho-
lesterolemia (Fig. 1C) upon HFC feeding. Historical data
of female APOE2ki mice (black bars) show that these
animals have elevated basal plasma TG levels that tended
to decrease with time (Fig. 1A), whereas free fatty acids
remained at basal levels (Fig. 1B) and total cholesterol
(TC) levels increased markedly throughout the dietary
period (Fig. 1C).8
Only Female ldlr/ and APOE2ki Mice Develop
Liver Inflammation. APOE2ki and ldlr/ mice
showed equal accumulation of lipid droplets in their livers
after 7 days of an HFC diet, which was comparable with
livers of control WT animals (Fig. 2A). Fig. 2B shows that
all mouse models had similar increases of liver TG after
short periods of HFC feeding (Fig. 2B). Liver TC showed
a similar response (Fig. 2C). HFC feeding thus induced a
degree of hepatic steatosis in ldlr/ and APOE2ki mice,
similar to what was observed in WT animals. These ob-
servations were confirmed by oil Red O staining (data not
shown).
Because HE staining revealed inflammatory clusters
(Fig. 2A) in the livers, antibodies against the macrophage
marker Mac1 were used to identify inflammatory cells.
The number of Mac1-positive cells was counted to deter-
mine the level of liver inflammation. Interestingly, WT
livers were completely free of inflammation upon HFC
feeding, whereas ldlr/ mice displayed inflammatory cell
clusters similar to those observed previously in APOE2ki
mice8 (Fig. 2D), albeit that the inflammation was less
severe in ldlr/ mice.
Gene expression analysis of several inflammatory genes
was performed in livers of the mouse models outlined at 2,
4, 7, and 21 days after HFC feeding. These genes were
monocyte chemoattractant protein 1 (Mcp1) (Fig. 2E),
CD68 (Fig. 2F), a macrophage marker, and tumor necro-
sis factor (TNF) (Fig. 2G), a cytokine. Expression of these
genes in ldlr/ and APOE2ki mice was strongly up-
regulated after HFC feeding. In contrast, control WT
mice showed only moderate increases in liver gene expres-
sion, apparently insufficient to drive an overt inflamma-
tory response as determined by liver histology.
Hence, in HFC-induced fatty liver, female APOE2ki
and ldlr/, but not WT mice, are sensitive to developing
inflammation, indicating that diet-induced steatosis does
not necessarily lead to the immediate development of an
inflammatory response in the liver.
Liver Gene Expression Profiling Reveals an Inflam-
matory Profile in ldlr/ but not in WT Female Mice.
To investigate the hepatic response to an HFC diet in
more detail, custom Taqman Low Density Array assays
were designed to compare the expression of 96 genes in-
volved either in lipid transport and metabolism or inflam-
mation. The expression of Mcp1, CD68, and TNF,
determined via quantitative PCR, was similar between
ldlr/ and APOE2ki mice (Fig. 2E-G). Additionally,
previous microarray analysis has already shown a pro-
Fig. 1. Plasma lipid levels of three female mouse models at several time
points after HFC treatment: 2, 4, 7, and 21 days compared with chow-fed
control mice. (A) Plasma triglycerides (TG). (B) Plasma free fatty acids (FFA)
and (C) plasma total cholesterol (TC). Bars represent time points (2, 4, 7,
and 21 days) and are grouped per genotype: WT mice (grey bars), ldlr/
mice (white bars), and APOE2ki mice (black bars). Statistical analysis was
performed using one-way analysis of variance with Dunnet’s posttest. *Sig-
nificantly different from chow diet levels.
476 WOUTERS ET AL. HEPATOLOGY, August 2008
Fig. 2. NASH parameters in female mice. (A) Representative pictures (magnification 200) of HE-stained liver sections were taken of female mice
after 7 days on an HFC diet. Arrows indicate inflammatory cell clusters. Liver (B) TG and (C) TC levels were quantified biochemically. (D) Liver sections
were stained for Mac1 (CD11b) and counted. Gene expression analysis with quantitative reverse-transcription PCR for three known inflammatory
marker genes: (E) monocyte chemoattractant protein 1, (F) CD68, and (G) TNF. Data were set relative to WT animals on a chow diet. Bars represent
time points (2, 4, 7, and 21 days) and are grouped per genotype: WT mice (grey bars), ldlr/ mice (white bars), and APOE2ki mice (black bars).
Statistical analysis was performed using one-way analysis of variance with Dunnet’s posttest. *Significantly different from chow diet levels.
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found inflammatory response after feeding female
APOE2ki mice an HFC diet.8 The response of ldlr/
mice to 7 days of HFC feeding was compared with that of
WT mice. Tables 1 and 2 show changes in expression
levels for these genes and indicate the pathway to which
each gene belongs. Genes involved in lipid metabolism
showed only few changes after 7 days of HFC diet in
either mouse model (Table 1). Inflammatory gene expres-
sion, including several known targets of NF-B, was
markedly up-regulated in female ldlr/ mice, but not in
female WT mice (Table 2). The inflammatory response
consisted mainly of the increased expression of macro-
phage-specific genes (Table 2), such as CD68, Fc Gamma
receptor 1, and Mac1, but not other immune cell-specific
genes such as CD19 (B cells), CD4 (T helper cells), CD8a
(cytotoxic T cells), and myeloperoxidase (neutrophils).
These data suggest that inflammation is mainly related to
macrophage accumulation and activation. Additionally,
Icam1 and Vcam1, both of which are involved in inflam-
matory cell migration and invasion, were up-regulated.
Additionally, genes involved in chemotaxis (Table 2),
such as ccl2 (mcp1), ccl3, and ptgs2 were strongly regu-
lated, indicating an important role of these gene products
in the development of hepatic inflammation.
Steatosis Is not Necessary for the Development of
HFC Diet-Induced Hepatic Inflammation. Male
ldlr/ and APOE2ki mice were put either on chow or an
HFC diet for 7 days (experiment 2). Male WT animals
were used as a control. Both male ldlr/ and APOE2ki
mice showed increased diet-induced plasma TG (Fig. 3 A)
and TC (Fig. 3 B) compared with control mice, although
APOE2ki mice were less responsive than ldlr/ mice.
The changes in TG were similar to those observed in
female ldlr/ mice, whereas APOE2ki mice differed in
their TG response, because female APOE2ki mice had
elevated starting levels of TG that did not change after
dietary intervention (Fig. 1A). Whereas the female
APOE2ki mice were more responsive with respect to
plasma TC (Fig. 1C), male APOE2ki mice had a lower
increase than ldlr/ mice.
Biochemical assessment of liver lipids showed no increase
in liver TG levels in male hyperlipidemic mice. Male WT
mice did show an increase in hepatic TG; however, the levels
after 7 days of an HFC diet did not exceed the ones displayed
in male ldlr/ and APOE2ki mice (Fig. 3C). On the other
hand, liver TC levels did rise significantly after an HFC diet
(Fig. 3D) in all models. Likewise, oil Red O staining did not
reveal overt steatosis (data not shown).
Lipid accumulation is generally considered an initial
and causal factor in the progression from steatosis to
NASH.11 Surprisingly, despite the lack of steatosis in
male mice, there was a severe inflammatory response, re-
flected by a three-fold to five-fold increase in Mac1-posi-
tive cells (Fig. 3E) and increased gene expression of Mcp1
(Fig. 3F), CD68 (Fig. 3G), and TNF (Fig. 3H) compared
with controls. These responses were more pronounced in
APOE2ki than in ldlr/ male mice. Overall, this indi-
cates that liver lipid accumulation is not a prerequisite for
hepatic inflammation to develop in these mouse models.
Foam Cells and Modified Lipoproteins in Hyper-
lipidemic Mice. Previously, we found that female
APOE2ki mice displayed an increase in size of CD68-


















Cd36 Lipid uptake 1.4 1.0 Fasn Lipid metabolism synthesis 0.5 0.4
Fabp1 Lipid uptake 1.2 0.9 LXRa Lipid metabolism synthesis 1.6 1.1
Lipc Lipid uptake 1.1 0.9 FXR Lipid metabolism synthesis 1.1 0.7
Lpl Lipid uptake 1.3 3.7* Scd1 Lipid metabolism synthesis 1.2 0.6
Lrp1 Lipid uptake 1.5* 1.1 Srebf1 Lipid metabolism synthesis 1.2 1.3
Slc27a1 Lipid uptake 1.1 0.9 Abca1 Cholesterol efflux 1.5 1.7*
Acaa1a Lipid oxidation and efflux 1.3 1.0 Cyp7a1 Cholesterol efflux 2.0 1.6
Acox1 Lipid oxidation and efflux 1.2 0.8 Scarb1 Cholesterol efflux 1.8 1.4*
Cpt1a Lipid oxidation and efflux 1.5 0.8 Adfp Intracellular lipid distribution 1.3 0.8
Crot Lipid oxidation and efflux 1.5 0.9 Cav1 Intracellular lipid distribution 1.2 0.9
Ech1 Lipid oxidation and efflux 0.9 0.8 Cav2 Intracellular lipid distribution 1.2 0.9
Hadha Lipid oxidation and efflux 1.1 1.0 M6prbp1 Intracellular lipid distribution 1.4 1.0
Mttp Lipid oxidation and efflux 1.0 0.8* Npc1 Intracellular lipid distribution 1.0 0.6
Ppara Lipid oxidation and efflux 1.4 0.9 Idi1 Cholesterol metabolism 0.2* 0.1*
Ppard Lipid oxidation and efflux 1.2 1.2 Insig2 Cholesterol metabolism 1.5 0.7
Pparg Lipid oxidation and efflux 1.1 1.1 Cyp8b1 Other 1.3 0.3
Table shows gene abbreviation and classification according to function. Expression is shown as fold change compared with levels of animals on standard chow diet
for WT and ldlr/ female mice after 7 days of an HFC diet. Values marked with an asterisk (*) indicate significant changes (Student t test) compared with chow.
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positive cells after dietary intervention.8 Immunostaining
against CD68 now indicated a comparable increase in size
rather than number of CD68-positive cells (that is, Kupffer
cells and macrophages) in livers of male and female ldlr/
and APOE2ki mice, but not of WT mice (Fig. 4A) (experi-
ments 1 and 2). Additionally, toluidine blue staining clearly
illustrated that the cells with a foamy appearance are located
in the sinusoidal space of the liver, suggesting that they are
Kupffer cells (KCs) (Fig. 4B). Further detail was provided
with electron microscopy (Fig. 4C). Electron microscopy
pictures showed clear differences between livers of the ani-
mals. KCs appeared to have more cytoplasm and filled a
larger fraction of the sinus, indicating that these cells are
swollen compared with chow-fed animals. In HFC-fed ani-
mals, the cytoplasm of KCs contained lipid droplets and
filled lysosomes. Moreover, these cells contained cholesterol
crystals, which is indicative of an uptake of cholesterol by
these cells.
Omitting Dietary Cholesterol Reduces Plasma Very
Low-Density Lipoprotein TC and Protects Against
Developing Hepatic Inflammation. A consistent find-
ing was that plasma TC was increased in the mouse mod-
els that developed hepatic inflammation. Accordingly, we
hypothesized that plasma TC is an important determi-
nant of hepatic inflammation. To test this hypothesis,
mice (both male and female) were put on the HCF and
HFnC diet (experiment 3). Omitting dietary cholesterol-
induced lower levels of very low-density lipoprotein
(VLDL)-TC than the HFC diet in both sexes of the hy-
perlipidemic mice (Fig. 5) lowered total plasma TC by
approximately 50% in APOE2ki and ldlr/ animals
(data not shown). Female WT mice also displayed lower-
ing of TC levels, whereas this was not observed in male
WT mice (data not shown).
Omission of dietary cholesterol did result in lower TG
and TC levels in WT controls but did not diminish liver
TG content in APOE2ki and ldlr/ mice (Fig. 6A,B). In
male mice, omitting cholesterol tended to enhance TG
content in the livers (Fig. 6C). The level of liver TC
remained low in female APOE2ki mice and in male
ldlr/ mice (Fig. 6 B,D).
Strikingly, Mac1 staining of liver sections showed that
macrophage infiltration was limited when ldlr/ and
APOE2ki mice of both sexes were put on the HFnC diet
(Fig. 6 E,F). Control mice did not show hepatic inflam-
mation in any of the conditions. HE staining revealed that
upon feeding male and female ldlr/ and APOE2Ki
mice an HFnC diet, no swollen, foamy KCs were detected


















Cd19 Cell markers 0.8 1.4 Socs3 Anti-inflammatory 1.3 1.9
Cd4 Cell markers 2.0 1.3 Cd14 General inflammation 1.8 4.5
Cd68 Cell markers 1.7 3.1*‡ Cd40 General inflammation 2.1 2.7*
Cd8a Cell markers 1.4 2.0 Cd80 General inflammation 2.7 2.7*
Fcgr1 Cell markers 2.2 2.4*‡ Cd86 General inflammation 2.2 3.0*
Itgam/Mac1 Cell markers 1.5 5.7*‡ CsfF General inflammation 0.6 0.9
Mpo Cell markers 3.0 7.9 Cxcl10 General inflammation 3.0 3.5*
Icam1 Cell markers 1.9 3.0 Ifng General inflammation 1.1 1.7
Vcam1 Cell markers 1.0 3.0 Il18 General inflammation 1.0 0.9
Vegfa Cell markers 1.1 1.0 Il18r1 General inflammation 1.9 4.0*
Ccl2/mcp1 Chemotaxis 3.0 9.5*† Il1b General inflammation 1.4 6.3*
Ccl3/mip1 Chemotaxis 3.4 11.2*† Il1r1 General inflammation 0.8 2.0*
Ccr2 Chemotaxis 1.8 1.9*† Il1r2 General inflammation 1.1 5.4
Ptgs2/Cox2 Chemotaxis 1.2 25.4*† Il6 General inflammation 1.6 6.0
Cat Oxidative stress 1.1 0.8 Il6ra General inflammation 0.6 0.7
Gsta2 Oxidative stress 0.5* 0.2* Nfkbia General inflammation 1.2 1.4
Hmox1 Oxidative stress 1.8 2.8* Saa1 General inflammation 2.3* 19.9*
Ikbkb Oxidative stress 1.0 1.3 Stat1 General inflammation 1.8 1.8*
Por Oxidative stress 1.3 0.8 Stat3 General inflammation 1.2 1.4
Bcl2 Apoptosis 1.2 2.0* Tlr2 General inflammation 2.3* 4.9*
Fasl Apoptosis 2.0 2.2* Tlr4 General inflammation 1.5 2.4*
Il10 Anti-inflammatory 2.5 1.7 Tnf General inflammation 3.0 10.0*
Il10ra Anti-inflammatory 1.5 2.9* Tnfrsf1a General inflammation 1.3 1.0
Socs1 Anti-inflammatory 2.6 2.3 Tnfrsf1b General inflammation 1.3 1.4
Table shows gene abbreviation and classification according to function. Expression is shown as fold change compared with levels of animals on standard chow diet
for WT and ldlr/ female mice after 7 days of an HFC diet. Values marked with an asterisk (*) indicate significant changes (Student t test) compared with chow.
†Regulated genes involved in chemotaxis.
‡Regulated genes used as cell markers.
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Fig. 3. Plasma and liver lipid levels in male mice. (A) Plasma TG and (B) Plasma TC were determined for male mice. Data are from animals fed
a chow diet or 7 days of an HFC diet. (C) Liver TG and (D) liver TC cholesterol levels were quantified biochemically. (E) Liver sections were stained
with antibodies against Mac1 (CD11b) and counted. Gene expression analysis with quantitative reverse-transcription PCR for three known
inflammatory genes: (F) monocyte chemoattractant protein 1, (G) CD68, and (H) TNF. Data was set relative to WT animals on a chow diet. Bars are
grouped per genotype: WT mice (grey bars), ldlr/ mice (white bars), and APOE2ki mice (black bars). Statistical analysis was performed using
Student t tests. *Significantly different from chow diet levels.
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(Fig. 7). Additional evidence was found with periodic
acid-Schiff–diastase staining. Supplementary Fig. 1
shows the lack of swollen KCs in HFnC-fed mice com-
pared with HFC-fed mice.
Accordingly, expression levels of Mcp1, CD68, and
TNF were down-regulated in female mice fed an HFnC
diet compared with those fed an HFC diet, and similar
trends were observed in male mice (Supplementary Fig.
2). Thus, lower levels of diet-induced VLDL-TC are as-
sociated with less hepatic inflammation in ldlr/ and
APOE2ki mice.
Discussion
This study clearly dissociates steatosis and inflamma-
tion in the livers of hyperlipidemic mice. High-fat feeding
induced a very early inflammatory response in the livers of
ldlr/ and APOE2ki female mice. In contrast, female
WT mice developed comparable steatosis but no inflam-
mation. Additionally, we found that in male mice, in-
flammation developed rapidly in the absence of steatosis.
Together, these results suggest that liver inflammation
can develop independently of steatosis upon high-fat
feeding. Subsequent experiments showed that omitting
cholesterol from the HFC diet prevented VLDL-TC ac-
cumulation and hepatic inflammation, while parameters
of steatosis remained largely unaffected. The presence of
bloated foamy KCs only in HFC-fed hyperlipidemic mice
suggests that scavenging of modified lipoproteins by KCs
may initiate this early inflammation.
Hyperlipidemic Mice Are Sensitive to Develop
Early Diet-Induced NASH. Until now, the best charac-
terized and most known models for NASH are mice de-
ficient for leptin (Ob/Ob) or mice fed a diet deficient in
methionine and choline (MCD).11 However, Ob/Ob
mice do not spontaneously develop liver inflammation
but require a second hit, like the administration of lipo-
polysaccharide to activate inflammatory signaling. Fur-
thermore, mutation of the leptin gene is not common in
human obese NAFLD patients. MCD-fed mice display
all the hallmarks of NASH, from steatosis to inflamma-
tion and fibrosis development. However, MCD-fed ani-
mals tend to lose weight and display lowered plasma
triglyceride (TG) levels11 and are therefore very different
from human NASH patients, who are mostly obese
and/or hyperlipidemic.
Dyslipidemia is commonly associated with NAFLD. It
has been postulated that abnormalities in lipid metabo-
lism—such as the increase of serum TG, TC, and low-
density lipoprotein–TC levels and decrease of high-
density lipoprotein–TC levels—may be contributing
factors of NASH development.12 Consequently, hyper-
lipidemic mice have been shown to develop diet-induced
NASH, not only in APOE2ki mice8 but also in ldlr/
and apolipoprotein E–deficient (apoe/) mice.13 Unlike
human subjects, WT mice carry most of their lipids in
high-density lipoproteins. In contrast, ldlr/ mice and
mice with various defects in apolipoprotein E have a hu-
man-like lipoprotein profile and may serve as physiologi-
cal mouse models to study the early progression of
NASH.
Medium-scale gene expression analysis showed that,
despite the presence of steatosis, not many lipid genes
were regulated in either ldlr/ or in WT control mice.
This is probably due to the early time point of 7 days of
high-fat feeding, which might be too early to evoke a large
transcriptional response of these genes. In line with this,
we have found that HFC-induced expression of genes
involved in lipid metabolism increases gradually with
Fig. 4. Hepatic foam cells. (A) Representative pictures (magnifi-
cation 400) of female APOE2ki liver sections stained against CD68
on a control chow diet and after 7 days of an HFC diet. (B)
Representative pictures (magnification 400) of toluidine-stained
liver sections from APOE2ki female mice on a chow diet and after 7
days of an HFC diet. Arrows indicate foamy KCs. (C) Representative
electron microscopy photographs (magnification 1550) of female
APOE2ki mice fed either a chow diet or an HFC diet. Arrows indicate
cholesterol crystals.
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time.8 Alternatively, the physiological response on lipids
may also be due to secondary feedback mechanisms reg-
ulated on the protein level rather than the gene level,
resulting in the lack of transcriptional regulation.
In contrast to the lipid genes, a large set of inflamma-
tory genes was regulated in the HFC-fed ldlr/ mice, but
not in WT mice, confirming our histological data. The
data show that the inflammatory response consisted
mainly of genes involved in chemotaxis and infiltration of
macrophages. Furthermore, many genes that were up-
regulated are known targets of the transcription factor
NF-B, suggesting an important role for this transcrip-
tion factor in response to HFC feeding and NASH devel-
opment, as has been postulated in HFC-fed APOE2ki
mice8 and in MCD-fed mice with a C57BL6/J back-
ground.14 Moreover, in NASH patients, NF-B expres-
sion was found to be up-regulated and correlated with
hepatic inflammation and fibrosis.15 The other regulated
genes are involved in several inflammatory signaling path-
ways, such as interleukin-18, interleukin-1, interleukin-6,
TNF, and Toll-like receptor signaling.
Steatosis Is Dissociated from the Development of
Hepatic Inflammation. In contrast to the two-hit
model, where hepatic steatosis is generally considered as
the first hit in the transition toward inflammation,1 male
mice had an inflamed liver even without steatosis. The
lack of steatosis development in male mice compared with
female mice was somewhat surprising, because estrogen is
normally known to be protective against NASH. It has
been shown that estrogen replacement in estrogen-defi-
cient mice lowers steatosis development.16 We postulate
that the lack of steatosis in male mice may be explained by
the fact that in the livers of male mice, peroxisome prolif-
erator-activated receptor isoforms are up to 100-fold
more active than in livers of female mice.17 Therefore, it is
conceivable that in male mice, activation of peroxisome
proliferator-activated receptor can compensate for the in-
creased lipid load. In support of this, we showed previ-
ously that feeding female APOE2ki mice an HFC diet for
short periods did not activate peroxisome proliferator-
activated receptor  significantly.8
Another gender-specific difference was found in
APOE2ki mice, as female APOE2ki mice displayed no
change in plasma TG levels, while male APOE2ki mice
did show increases upon HFC intake. A possible explana-
tion for this observation may be that estrogens can in-
crease activities of hepatic lipase and lipoprotein lipase,18
which could lead to increased hydrolysis of TG in the
plasma.
Fig. 5. Treatment with an HFnC diet lowers VLDL cholesterol levels. Shown are lipoprotein fractions after 7 days of an HFC diet and 7 days of an
HFnC diet in (A) female ldlr/ mice, (B) female APOE2ki mice, (C) male ldlr/ mice, and (D) male APOE2ki mice.
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Fig. 6. Omitting cholesterol from the high-fat diet prevents inflammation development without affecting steatosis. Biochemical measurements of
liver lipids are shown for TG in (A) female and (C) male mice and for TC content in (B) female and (D) male mice after 7 days of treatment with
an HFC or HFnC diet. Counting of Mac1-positive cells is shown in liver sections of (E) female and (F) male mice. Data are shown from WT mice (grey
bars), ldlr/ mice (white bars), and APOE2ki mice (black bars). Statistical analysis was performed using Student t tests. *Significantly different from
HFC diet levels.
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Clearly, steatosis is not mandatory for progression to-
ward hepatic inflammation in the mouse models used. In
fact, others have postulated TG accumulation in the liver
may even serve as a protective mechanism against inflam-
mation development, by acting as a reservoir for harmful
free fatty acids.6
Plasma Cholesterol May Mediate Hepatic Inflam-
mation. We found a correlation between plasma TC and
the development of hepatic inflammation, rather than
with steatosis. This observation led us to hypothesize
plasma TC as an important cause for the development of
inflammation in these animals. Feeding the animals an
HFnC diet kept plasma VLDL-TC low and prevented the
development of inflammation in all hyperlipidemic
mouse models without diminishing liver TG. Liver TG
even increased in male APOE2ki mice without any appar-
ent explanation, an observation that further strengthens
the dissociation of steatosis from hepatic inflammation.
Recent publications also point to the importance of
dietary cholesterol in liver inflammation and NASH both
in rodents5,19 and rabbits.20 Moreover, in human subjects,
it was found that high-cholesterol feeding increased C-re-
active protein and serum amyloid A levels.21
Recently, Mari et al.5 reported that high-cholesterol
feeding may serve as the first hit that sensitizes rat livers to
develop hepatic inflammation after exposure to a second
hit, like TNF or FAS. In contrast, we observed that high-
cholesterol feeding alone is sufficient to cause a very early
inflammatory response. Several differences between the
studies could explain this dissimilarity. First, Mari et al.
used rats, which are known to be more resistant to devel-
oping hyperlipidemia than mice.22 Our study incorpo-
rated mouse models with genetic modifications
specifically involved in plasma lipoprotein clearance and
lipid metabolism. Consequently, it is possible that other
mechanisms may be of greater importance in a rat model.
Fig. 7. An HFnC diet does not induce hepatic foam
cells. Representative pictures (magnification 400) of
HE-stained liver sections from ldlr/ and APOE2ki
male and female mice after 7 days on an HFC and
HFnC diet. Arrows indicate foamy KCs. Inserts show
foamy KCs when present on higher magnification.
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Second, the manner of inducing steatosis was different.
We used a mild high-fat diet, whereas Mari et al. used
choline deficiency to evoke steatosis in their rats. More-
over, their diet contained high levels of cholesterol (2%)
supplemented with sodium cholate, but no elevated TG
content. In these concentrations, both cholesterol and
cholate have been shown to induce an inflammatory re-
sponse in the livers of C57BL6/J mice.23 The diet used in
our study contained elevated TG levels to evoke steatosis
and had cholesterol levels of only 0.2%, which is much
closer to the average daily cholesterol intake in humans.
Therefore, the diet used in our study appears to be more
relevant in terms of induction of NASH in human pa-
tients.
Interestingly, in line with the present observations,
male apoe/ mice were shown to develop liver inflam-
mation when fed cholesterol levels of 0.25% and higher.24
This again points to an important role for dietary choles-
terol in hepatic inflammation. However, this inflamma-
tory response was investigated after several weeks of a
high-fat diet and in the presence of steatosis. Our data
suggest a very early impact of dietary cholesterol—possi-
bly in the form of plasma VLDL-TC—on hepatic in-
flammation, regardless of steatosis development.
KCs May Initiate Early Hepatic Inflammation by
Scavenging Modified Lipoproteins. The mice used in
our study are commonly used in atherosclerosis research,
because they have atherogenic lipoprotein profiles due to
increased modified remnant lipoproteins (oxidized low-
density lipoprotein).25 Oxidized low-density lipoprotein
(LDL) binds to the scavenger receptor CD36 and scaven-
ger receptor class A (SRA), which are also present on KCs,
and can trigger an inflammatory response.26,27 In livers of
the mice with hepatic inflammation, we found bloated,
foamy cells, which resemble lipid-laden KCs, as has been
described.13,28
Injection of modified LDL has been shown to result in
an immediate uptake preferentially by nonparenchymal
cells such as KCs.29,30 Moreover, it has been shown that
modified LDL injection in mice activates the hepatic
NF-B pathway and subsequent inflammation.31 There-
fore, it is possible that in our hyperlipidemic mouse mod-
els, circulating levels of modified lipoproteins are
scavenged by hepatic KCs, thereby triggering an inflam-
matory response. On the other hand, in WT mice, cho-
lesterol-rich lipoproteins are rapidly cleared from the
blood by hepatocytes via the LDL receptor before they
can be modified and taken up by KCs.
Taken together, it is feasible that oxidized LDL may be
a causal factor for the development of diet-induced he-
patic inflammation. A paper have shown a correlation
between postprandial LDL-conjugated dienes and he-
patic necroinflammation and fibrosis development in hu-
man subjects.32 LDL levels, possibly in modified form,
were also found to be increased in NASH patients,12 con-
firming the clinical relevance of our findings.
In conclusion, this study demonstrates that dietary
cholesterol, possibly in the form of modified plasma li-
poproteins, rather than liver steatosis, may be a risk factor
for NASH development. Currently, most therapies for
NASH patients involve weight loss, and most diagnostic
tests of NASH severity depend solely on the degree of
steatosis. Further studies may unravel the exact contribu-
tion of cholesterol to the risk of developing NASH and
may provide evidence for alternative strategies for new
therapies and markers for diagnostic tests.
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